Navigation Links
Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
Date:8/2/2011

PARSIPPANY, N.J., Aug. 2, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that new preclinical data evaluating the safety of DepoFoam® with DEPC (a novel excipient) will be presented in two podium sessions at the 38th Annual Meeting & Exposition of the Controlled Release Society (CRS) in National Harbor, Md. DepoFoam is Pacira's proprietary, extended release drug delivery technology, which is a key component of EXPAREL™ (bupivacaine extended-release liposome injection), the company's lead investigational product candidate for postsurgical pain management.

The first abstract, titled "Quantitative WholeBody Autoradiography Following Single Subcutaneous Injection of [114C] 2erucoyl)DEPC DepoFoam Formulation in Rats," will be presented on Tuesday, August 2, 2011, at 4:30 p.m. EDT.  The second abstract, titled "Safety Evaluation of a Novel Pharmaceutical Excipient (DEPC) in EXPAREL, an Extended-Release Liposomal Formulation of Bupivacaine," will be presented on Tuesday, August 2, 2011, at 5 p.m. EDT. Both abstracts are being presented at a major medical meeting for the first time.

"These new data add to the growing body of evidence supporting the safety of DepoFoam as a proprietary, extended release drug delivery technology," said David Stack, president and chief executive officer of Pacira Pharmaceuticals, Inc. "As DepoFoam is the carrier vehicle for our lead product candidate, EXPAREL, these presentations mark another important safety milestone for the clinical community. We believe these data, combined with the other positive clinical and pre-clinical data we have previously presented, further validate the potential safety and utility of EXPAREL in postsurgical pain management, should it be approved by the Food and Drug Administ
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
2. Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index
3. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
4. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
5. Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference
6. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
7. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
8. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
9. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
10. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and ZURICH , May 17, ... Agency for Science, Technology and Research (A*STAR) and ... first healthy volunteer has been dosed in a Phase 1 ... Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this ... this novel vaccine candidate and its potential to protect against ...
(Date:5/16/2013)... SAN FRANCISCO , May 16, 2013  Nektar Therapeutics, ... Howard W. Robin , is scheduled to ... New York at the Sheraton New ... Eastern time. The presentation will be accessible via ... Events Calendar section of the Nektar website: http://www.nektar.com . ...
(Date:5/16/2013)... , May 16, 2013  Alere Inc. (NYSE: ... take charge of their health at home through the merger ... dividend of $3.00 per share on its Series B Convertible ... July 15, 2013 to holders of record of Series B ... Such payment will cover the amount of all ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Acorda,Therapeutics (Nasdaq: ACOR) today announced that Andrew Goodman,M.D., ... University,of Rochester, will present data from Acorda's MS-F203 ... at the,upcoming American Academy of Neurology (AAN) meeting. ... 2, 2007 at 4:15 pm,Eastern Time (ET). This ...
... Mice Show Reduction of Enzyme Substrate, CRANBURY, ... a biopharmaceutical company developing,small-molecule, orally administered pharmacological ... announced today that the,Company will present results ... compound in development for the,treatment of Fabry ...
Cached Medicine Technology:Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data,Selected for Scientific Highlights Program at the American Academy,of Neurology Meeting 2Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 2Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 3
(Date:5/19/2013)... Aires, Argentina: Yoga classes ( clases de Yoga ) ... the Sivananda Yoga Vedanta Center. The center is ... Classes are 90 minutes and are offered all week ... calm environment, allowing visitors to enjoy the benefits of ... others. , The Yoga classes follow the following principles: ...
(Date:5/19/2013)... May 19, 2013 The legal team ... YazSideEffects.com in a concerted effort to connect women and ... birth control drugs Yaz, Yasmin & Ocella with the ... of information on the notorious birth control drugs as ... Pharmaceuticals. , Yaz, Yasmin & Ocella were very ...
(Date:5/18/2013)... Daily Gossip issued a press release last week to announce ... Colston, Daily Gossip’s spokesperson, told the press that the magazine ... Fat Loss Plan . , Shaun Hadsall was the ... time when nutritionists and fat loss gurus constantly told people ... diet is based on the Macro-Patterning scheme, according ...
(Date:5/18/2013)... Also known as bariatric surgery , ... surgery that guarantees patients long-term weight loss. Dr. Naim ... give readers a brief tutorial on this revolutionary weight ... New York City’s Mount Sinai School of Medicine. After ... fellowship in Minimally Invasive Bariatric Surgery. He has also ...
(Date:5/18/2013)... News) -- Children who swallow high-powered magnets often need ... according to a new study. The researchers, from ... found that more than 79 percent of children who ... an endoscopic procedure, in which a tube containing a ... percent of these cases can be treated through observation ...
Breaking Medicine News(10 mins):Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Swallowing Magnets Can Be Fatal for Children 2
... Efficiency, SAN RAMON, Calif., May 29 ... specializes in enabling,transformation of its clients, business and ... $1.5 million five-year contract with Golden Living, a,network ... nursing,facilities and 19 assisted living facilities in 22 ...
... Ill.--The interaction of sex, age and ethnicity has a ... (MCRC) patients, a study led by researchers at the ... Center suggests. , While age and ethnicity ... the study found that gender also plays an important ...
... Patients suffering from hemineglect cannot attend to, and hence ... sometimes these ignored stimuli may be processed without awareness. ... of Cortex, Jerome Sackur and colleagues at Unit de ... hemineglect is not limited to low level features of ...
... Be Part of the Festivities, NEW YORK, May 29 ... Drug-Free America(R) and MetLife Foundation,found that parents, personal past experiences ... the rules and limits they set for,their teens during this ... who drank or used drugs at their own,proms or graduations ...
... of studies features biomechanical analysis of footwear, INDIANAPOLIS, ... footwear option during warm summer months may,experience lower leg ... presented today at the 55th Annual Meeting of the ... are very common, and this study began with the ...
... 29 DigitalRodeo.com has announced,today that they have coordinated ... on Saturday, May 31st at Hotel Indigo, on,West End, ... country music community that offers a,place for you to ... have an,unlimited opportunity to discover the world of country ...
Cached Medicine News:Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 2Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 3Health News:USC study finds sex, age and ethnicity assciated with colorectal cancer survival 2Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 2Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 3Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 4Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 5Health News:Flip-Flops, Heels Examined for Performance, Impact 2Health News:Flip-Flops, Heels Examined for Performance, Impact 3Health News:DigitalRodeo.com Lines Up Entertainment for Rhinestone Cure 2
Using the patient's own blood pressure as the driving force, CAVR circulates cold blood through the Level 1 heat exchanger and returns it to the patient at body temperature for rapid core rewarming....
... HOTLINE can deliver normothermic fluid to your ... HOTLINE tubing design surrounds the patient line ... eliminating patient line cool down. The HOTLINE ... position, requires less priming volume, and is ...
... control panel is conveniently located on the swivel ... whether standing or sitting. The ventilator control panel ... numerics. The ventilator has CMV, PCV and SIME ... in two lengths facilitates both the placing of ...
... provides high quality ventilation and monitoring ... technologies of the AV2+ ventilator, breathing ... GS user-friendly and intuitive. , ... GS is the perfect introduction to ...
Medicine Products: